These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 11195399

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance.
    Saudan P, Halabi G, Perneger T, Wasserfallen JB, Wauters JP, Martin PY, Western Switzerland Dialysis Group.
    J Nephrol; 2006; 19(1):91-6. PubMed ID: 16523432
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Erythropoietin resistance in patients on continuous ambulatory peritoneal dialysis.
    Nakamoto H, Kanno Y, Okada H, Suzuki H.
    Adv Perit Dial; 2004; 20():111-6. PubMed ID: 15384808
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lymphocyte subset counts in continuous ambulatory peritoneal dialysis patients in relation to administration of recombinant human erythropoietin and angiotensin-converting enzyme inhibitors.
    Grzegorzewska AE, Leander M.
    Adv Perit Dial; 2002; 18():6-11. PubMed ID: 12402577
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.
    Vegter S, Perna A, Hiddema W, Ruggenenti P, Remuzzi G, Navis G, Postma MJ.
    Pharmacogenet Genomics; 2009 Sep; 19(9):695-703. PubMed ID: 19696696
    [Abstract] [Full Text] [Related]

  • 13. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F, Herrero JA, Montenegro J, Fernandez C, Gandara A, Conesa J, Rivera MT, Torrente J, Portolés J, Gomez-Martino JR.
    J Nephrol; 2003 Sep; 16(5):697-702. PubMed ID: 14733416
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Sep; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade.
    Moon JY, Jeong KH, Paik SS, Han JJ, Lee SH, Lee TW, Ihm CG, Kim MJ, Chung JH.
    Nephron Clin Pract; 2009 Sep; 111(2):c110-6. PubMed ID: 19142023
    [Abstract] [Full Text] [Related]

  • 18. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM, Tareeva IE, Nosikov VV, Kamyshova ES, Gorashko NM, Chistiakov DA, Okonova EB, Troepol'skaia OV.
    Ter Arkh; 1999 Sep; 71(6):30-4. PubMed ID: 10420452
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of high dose losartan on erythropoietin resistance in patients undergoing haemodialysis.
    Odabas AR, Cetinkaya R, Selcuk Y, Keles S, Bilen H.
    Panminerva Med; 2003 Mar; 45(1):59-62. PubMed ID: 12682621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.